CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesionsMichal Zimmermann, Daniel Durocher|Nature|2018Cited by 415
The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivityJohn M. Maris, Michal Zimmermann|Research Square|2025Cited by 1